β1-blockers in the reduction of bleeding risk in patients prescribed with potent dual antiplatelet therapy after acute coronary syndrome or percutaneous coronary intervention

CONCLUSION: β1-blockers might be beneficial for the reduction of bleeding risk in potent dual antiplatelet therapy patients with ACS or undergoing PCI.PMID:37783287 | DOI:10.1016/j.hjc.2023.09.017

Source: Hellenic Journal of Cardiology - October 2, 2023 Category: Cardiology Authors: Shizhao Zhang Yangxun Wu Chao Lv Haiping Liu Yuyan Wang Lisha Dong Yuqi Liu Shengshu Wang Jianjun Jia Tong Yin Source Type: research